Protect Pharmaceutical Corporation
PRTT · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $132,262 | $136,158 | $81,799 | $78,794 |
| % Growth | -2.9% | 66.5% | 3.8% | – |
| Cost of Goods Sold | $59,706 | $62,848 | $40,223 | $34,429 |
| Gross Profit | $72,556 | $73,310 | $41,576 | $44,365 |
| % Margin | 54.9% | 53.8% | 50.8% | 56.3% |
| R&D Expenses | $2,538 | $4,789 | $1,746 | $1,909 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $12,379 | $20,981 | $14,573 | $14,578 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $14,917 | $25,770 | $16,319 | $16,487 |
| Operating Income | $57,639 | $47,540 | $25,257 | $27,878 |
| % Margin | 43.6% | 34.9% | 30.9% | 35.4% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $57,639 | $47,540 | $25,257 | $27,878 |
| Tax Expense | $1,312 | $1,628 | $2,815 | $7,670 |
| Net Income | $56,327 | $45,912 | $22,442 | $20,208 |
| % Margin | 42.6% | 33.7% | 27.4% | 25.6% |
| EPS | 0.98 | 0.8 | 0.43 | 0.36 |
| % Growth | 22.5% | 86% | 19.4% | – |
| EPS Diluted | 0.98 | 0.8 | 0.43 | 0.36 |
| Weighted Avg Shares Out | 57,451 | 57,451 | 52,780 | 56,251 |
| Weighted Avg Shares Out Dil | 57,451 | 57,451 | 52,780 | 56,251 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $168 | $228 | $237 |
| EBITDA | $57,639 | $47,708 | $25,485 | $28,115 |
| % Margin | 43.6% | 35% | 31.2% | 35.7% |